🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Florid › Tampa

Etid klinik pou Sendwòm myelodisplastik nan Tampa, FL

19 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Tampa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Moffitt Cancer Center-International Plaza, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Ap rekriteFaz 1
  • Moffitt Cancer Center, Tampa
Laj 12 a 78 · Tout sèks · Mizajou Sep 29, 2026 · NCT03802695

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Ap rekriteFaz 1/2
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198

A Study of BGB-11417 in Participants With Myeloid Malignancies

Ap rekriteFaz 1/2
  • Tampa General Hospital, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04771130

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Ap rekriteFaz 3
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06499285

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Ap rekriteFaz 2
  • H. Lee Moffitt Cancer Center and Research Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT04419649

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Ap rekriteFaz 1
  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06656494

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Moffitt Cancer Center, Tampa
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Ap rekriteFaz 2
  • Moffitt Cancer Center, Tampa
Laj 1 a 60 · Tout sèks · Mizajou Mar 12, 2026 · NCT03970096

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Ap rekriteFaz 1
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05143996

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Ap rekriteFaz 1
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Dec 23, 2025 · NCT04245397

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Tampa
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Ap rekriteFaz 1
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

Ap rekriteFaz 1
  • Moffitt Cancer Center, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2025 · NCT06297941

A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Ap rekriteFaz 1/2
  • H. Lee Moffitt Cancer Center & Research Institute, Tampa
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2019 · NCT03886662

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Tampa

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.